Menu

 

Letter

Opening up data at the EMA

EMA’s response to articles

BMJ 2011; 342 doi: http://dx.doi.org/10.1136/bmj.d3838 (Published 20 June 2011)
Cite this as: BMJ 2011;342:d3838

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Andreas Pott, acting executive director1
  1. 1European Medicines Agency, London E14 4HB, UK
  1. press{at}ema.europa.eu

Two recent BMJ articles have given the European Medicines Agency (EMA) useful feedback from the academic community on its provision of information on the scientific review of medicines.1 2 The agency is grateful for and open to suggestions on how this can be improved.

The authors of both articles ignore recent steps that the agency has taken to improve the transparency …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Subscribe

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

Latest comments and most commented

THIS WEEK'S POLL

Read related article

See previous polls